NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock Price (Quote)

$182.50
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $182.50 $182.50 Friday, 27th May 2022 ALXN stock ended at $182.50. During the day the stock fluctuated 0% from a day low at $182.50 to a day high of $182.50.
90 days $182.50 $182.50
52 weeks $174.72 $187.45

Historical Alexion Pharmaceuticals prices

Date Open High Low Close Volume
2019-01-14 $110.02 $110.33 $107.53 $107.58 1 681 793
2019-01-11 $110.68 $111.53 $108.75 $111.13 1 339 548
2019-01-10 $109.15 $111.49 $108.45 $110.93 1 467 699
2019-01-09 $108.99 $110.74 $108.32 $109.96 1 553 265
2019-01-08 $108.65 $110.49 $105.20 $108.61 1 766 466
2019-01-07 $105.65 $108.98 $104.70 $107.94 1 983 675
2019-01-04 $101.88 $107.30 $101.80 $106.00 2 349 942
2019-01-03 $100.15 $103.88 $99.12 $100.21 3 296 547
2019-01-02 $95.84 $99.05 $95.16 $98.05 1 359 749
2018-12-31 $98.06 $99.81 $96.39 $97.36 1 310 388
2018-12-28 $98.52 $99.27 $96.57 $97.21 1 407 224
2018-12-27 $95.83 $98.19 $93.79 $98.10 1 466 702
2018-12-26 $94.95 $97.87 $94.04 $97.87 1 945 266
2018-12-24 $93.23 $96.57 $92.56 $93.94 1 774 805
2018-12-21 $101.19 $102.37 $93.67 $94.63 5 336 786
2018-12-20 $102.07 $105.02 $99.75 $101.22 2 959 329
2018-12-19 $106.39 $107.72 $100.93 $102.78 2 526 742
2018-12-18 $110.13 $110.74 $105.41 $105.99 2 012 300
2018-12-17 $109.36 $114.07 $108.21 $109.53 2 159 290
2018-12-14 $111.59 $112.24 $108.86 $109.43 2 120 832
2018-12-13 $117.27 $118.26 $112.33 $112.43 2 564 620
2018-12-12 $117.24 $118.76 $116.00 $117.01 1 395 861
2018-12-11 $115.96 $117.11 $113.28 $114.83 1 403 453
2018-12-10 $115.65 $115.99 $111.75 $114.65 1 670 714
2018-12-07 $119.83 $120.98 $114.40 $115.60 1 229 654
Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... ALXN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT